Mylan Takes Benicar Patent Dispute To The Supreme Court
Mylan Pharmaceuticals Inc. has asked the U.S. Supreme Court to decide whether Apotex Inc. can continue its drug patent infringement lawsuit despite the fact that the disputed patent was disclaimed in...To view the full article, register now.
Already a subscriber? Click here to view full article